Q121 多学科专家会诊技术在肝癌患者诊断和治疗中的作用？
肝癌治疗方法有很多种；按照国家卫生和计划生育委员会拟定的原发性肝癌诊疗规范，同一期的肝癌患者往往可以接受多种治疗手段，而具体到实施时选择何种治疗手段需要专业医师通过讨论的形式确定最合适的治疗手段。因此多学科专家会诊技术可以使不同科室的专家针对一位患者的病情进行讨论，最终形成最合适的诊断和诊疗意见。
（孙惠川）
参考文献
[1] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet, 2015, 385(9963): 117-171.
[2] Michelotti G A, Machado M V, Diehl A M, et al. NAFLD, NASH and liver cancer[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(11): 656-665.(https://www.daowen.com)
[3] Chen J G, Egner P A, Ng D, et al. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China[J]. Cancer Prev Res (Phila), 2013, 6(10): 1038-1045.
[4] Qu C, Chen T, Fan C, et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial[J]. PLo S Med, 2014, 11(12): e1001774.
[5] Sun Z, Chen T, Thorgeirsson S S, et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China[J]. Carcinogenesis, 2013, 34(8): 1800-1805.
[6] 国家卫生计生委医政医管局. 原发性肝癌诊疗规范(2017年版) [EB/OL]. (2016-07)[2017-04] http://www.moh.gov.cn/yzygj/s7659/201706/80abf02a86c048fcb130e5e298f7aeee.shtml.
[7] Wong G L, Chan H L, Wong C K, et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J Hepatol, 2014, 60(2): 339-345.
[8] Seo S I, Kim H S, Kim W J, et al. Diagnostic value of PVIKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma[M]. World J Gastroenterol, 2015, 21: 3928-3935.
[9] Yin J, Li N, Han Y, et al. Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study[M]. J Clin Oncol, 2013, 31(29): 3647-3655.